Patterns of Caffeine Use and Validation of Assessment in Psychiatric Population: An Implication in Primary Care Setting.
Caffeine
gas chromatograph mass spectrometer
primary care physicians
psychiatric problems
Journal
Journal of family medicine and primary care
ISSN: 2249-4863
Titre abrégé: J Family Med Prim Care
Pays: India
ID NLM: 101610082
Informations de publication
Date de publication:
Oct 2020
Oct 2020
Historique:
received:
25
04
2020
revised:
10
06
2020
accepted:
08
07
2020
entrez:
7
1
2021
pubmed:
8
1
2021
medline:
8
1
2021
Statut:
epublish
Résumé
Caffeine use and abuse is a concern among treatment seekers for psychological problems. This aspect has not been documented an Indian context as well as its relevance in primary care setting. The aim of the present study was to explore and compare the caffeine intake and prevalence in Indian psychiatric patients and healthy subjects. Caffeine analysis in urine samples was carried out using a gold technique, gas chromatograph and mass selective detectors. This analytical technique is highly sensitive for identification of unambiguous compound. Two hundred and forty-three subjects having psychiatric disorders, along with forty-two healthy subjects were included in the study. They were assessed by using structured interview for caffeine use and screened for substance dependence as well. One hundred twenty-eight subjects had history of substance use along with other comorbid psychiatric problems The mean of caffeine values was 1459 ± 1140 ng/mL, Whereas 42 subjects in control group (male 26, female 16) in the age group of 21-60 years had the mean caffeine levels of 1023 ± 788.8 ng/mL. The Caffeine use was significantly higher ( It implies the need to enable and sensitize the primary care physicians in screening and educating treatment seekers with psychiatric morbidities for the management of caffeine use.
Sections du résumé
BACKGROUND
BACKGROUND
Caffeine use and abuse is a concern among treatment seekers for psychological problems. This aspect has not been documented an Indian context as well as its relevance in primary care setting. The aim of the present study was to explore and compare the caffeine intake and prevalence in Indian psychiatric patients and healthy subjects.
MATERIALS AND METHODS
METHODS
Caffeine analysis in urine samples was carried out using a gold technique, gas chromatograph and mass selective detectors. This analytical technique is highly sensitive for identification of unambiguous compound. Two hundred and forty-three subjects having psychiatric disorders, along with forty-two healthy subjects were included in the study. They were assessed by using structured interview for caffeine use and screened for substance dependence as well.
RESULTS
RESULTS
One hundred twenty-eight subjects had history of substance use along with other comorbid psychiatric problems The mean of caffeine values was 1459 ± 1140 ng/mL, Whereas 42 subjects in control group (male 26, female 16) in the age group of 21-60 years had the mean caffeine levels of 1023 ± 788.8 ng/mL. The Caffeine use was significantly higher (
CONCLUSIONS
CONCLUSIONS
It implies the need to enable and sensitize the primary care physicians in screening and educating treatment seekers with psychiatric morbidities for the management of caffeine use.
Identifiants
pubmed: 33409197
doi: 10.4103/jfmpc.jfmpc_698_20
pii: JFMPC-9-5252
pmc: PMC7773091
doi:
Types de publication
Journal Article
Langues
eng
Pagination
5252-5255Informations de copyright
Copyright: © 2020 Journal of Family Medicine and Primary Care.
Déclaration de conflit d'intérêts
There are no conflicts of interest.
Références
Addict Behav. 2015 Apr;43:60-5
pubmed: 25576951
Br J Addict. 1987 May;82(5):503-9
pubmed: 3474007
Eur Arch Psychiatry Clin Neurosci. 1996;246(2):83-92
pubmed: 9063913
Br J Psychiatry. 1993 Apr;162:543-5
pubmed: 8481748
Drug Alcohol Depend. 1998 Oct 1;52(2):99-107
pubmed: 9800139
J Caffeine Res. 2011 Dec;1(4):219-225
pubmed: 24761264
J Alzheimers Dis. 2010;20 Suppl 1:S239-48
pubmed: 20164571
Life Sci. 1984 Sep 17;35(12):1241-7
pubmed: 6207403
J Psychopharmacol. 2015 Dec;29(12):1236-47
pubmed: 26508718
Biol Psychiatry. 1989 Jan 15;25(2):141-52
pubmed: 2539200
J Caffeine Adenosine Res. 2020 Mar 1;10(1):4-11
pubmed: 32181442
J Okla State Med Assoc. 2004 Dec;97(12):538-42
pubmed: 15732884
Nutrients. 2019 Jan 29;11(2):
pubmed: 30699902
Food Chem Toxicol. 2002 Sep;40(9):1243-55
pubmed: 12204388
Biol Psychiatry. 1991 Nov 15;30(10):973-84
pubmed: 1756202
J Nerv Ment Dis. 1995 Sep;183(9):559-65
pubmed: 7561817